VIKING THERAPEUTICS INC's ticker is VKTX and the CUSIP is 92686J106. A total of 143 filers reported holding VIKING THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.72 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,175,953 | -63.5% | 557,900 | -46.6% | 0.00% | -66.7% |
| Q2 2023 | $16,928,379 | -2.2% | 1,044,317 | +0.5% | 0.00% | -25.0% |
| Q1 2023 | $17,304,212 | +185.8% | 1,039,292 | +61.4% | 0.00% | +300.0% |
| Q4 2022 | $6,054,126 | +1227.7% | 644,056 | +285.3% | 0.00% | – |
| Q3 2022 | $456,000 | -33.2% | 167,147 | -29.2% | 0.00% | – |
| Q2 2022 | $683,000 | -70.0% | 236,250 | -68.8% | 0.00% | – |
| Q1 2022 | $2,273,000 | +27.0% | 757,845 | +94.8% | 0.00% | – |
| Q4 2021 | $1,790,000 | -16.8% | 389,099 | +13.5% | 0.00% | – |
| Q3 2021 | $2,152,000 | -9.4% | 342,745 | -13.6% | 0.00% | – |
| Q2 2021 | $2,375,000 | +27.6% | 396,530 | +34.8% | 0.00% | – |
| Q1 2021 | $1,861,000 | -39.3% | 294,199 | -46.0% | 0.00% | – |
| Q4 2020 | $3,066,000 | +14.6% | 544,570 | +18.4% | 0.00% | – |
| Q3 2020 | $2,676,000 | -7.7% | 459,934 | +14.5% | 0.00% | -100.0% |
| Q2 2020 | $2,898,000 | +34.8% | 401,808 | -12.6% | 0.00% | 0.0% |
| Q1 2020 | $2,150,000 | -58.0% | 459,508 | -28.1% | 0.00% | -66.7% |
| Q4 2019 | $5,122,000 | +40.6% | 638,700 | +20.7% | 0.00% | +200.0% |
| Q3 2019 | $3,642,000 | -30.8% | 529,300 | -16.6% | 0.00% | -66.7% |
| Q2 2019 | $5,265,000 | -68.3% | 634,311 | -62.1% | 0.00% | -62.5% |
| Q1 2019 | $16,631,000 | +49.0% | 1,673,174 | +14.7% | 0.01% | +33.3% |
| Q4 2018 | $11,163,000 | -56.0% | 1,459,245 | +0.3% | 0.01% | -45.5% |
| Q3 2018 | $25,342,000 | +236.8% | 1,454,701 | +83.5% | 0.01% | +266.7% |
| Q2 2018 | $7,524,000 | +11475.4% | 792,871 | +5194.6% | 0.00% | – |
| Q1 2018 | $65,000 | -39.8% | 14,975 | -73.5% | 0.00% | – |
| Q3 2017 | $108,000 | +414.3% | 56,461 | +239.6% | 0.00% | – |
| Q2 2016 | $21,000 | +10.5% | 16,624 | +27.4% | 0.00% | – |
| Q1 2016 | $19,000 | – | 13,044 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| APIS CAPITAL ADVISORS, LLC | 148,000 | $1,638,360 | 2.12% |
| Sio Capital Management, LLC | 595,002 | $6,586,672 | 2.04% |
| 5AM Venture Management, LLC | 585,000 | $6,475,950 | 1.86% |
| Artia Global Partners LP | 383,580 | $4,246,231 | 1.76% |
| Integral Health Asset Management, LLC | 800,000 | $8,856,000 | 1.23% |
| Boxer Capital, LLC | 2,000,000 | $22,140,000 | 1.18% |
| DAFNA Capital Management LLC | 319,655 | $3,538,581 | 1.10% |
| Affinity Asset Advisors, LLC | 332,600 | $3,681,882 | 1.04% |
| MPM BioImpact LLC | 325,000 | $3,597,750 | 0.96% |
| Affinity Asset Advisors, LLC | 300,000 | $3,321,000 | 0.93% |